查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1924699

醫用胃造瘻管市場按材質、適應症、病患年齡、最終用戶和通路分類－2026-2032年全球預測

Medical Gastrostomy Tube Market by Tube Material, Indication, Patient Age, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用胃造瘻管市場價值將達到 11.1 億美元，到 2026 年將成長至 12.1 億美元，到 2032 年將達到 21.9 億美元，年複合成長率為 10.22%。

關鍵市場統計數據
基準年 2025 11.1億美元
預計年份：2026年 12.1億美元
預測年份 2032 21.9億美元
複合年成長率 (%) 10.22%

闡明胃造瘻管在醫療保健環境中的臨床重要性和不斷變化的作用，同時強調其操作性和以病人為中心的重要性。

胃造瘻管是經腸營養和藥物輸注的重要途徑，適用於無法充分經口攝取或吸收營養的患者。這些裝置種類繁多，從傳統的外置管到旨在最大限度減少社會歧視並方便患者日常生活的低調內置系統，應有盡有。隨著臨床實踐向門診和居家照護的轉變，胃造瘻管的應用範圍也從急性醫院擴展到慢性神經系統疾病（可損害吞嚥和消化功能）、腫瘤支持治療以及複雜遺傳性疾病的長期管理等領域。

產品創新、醫療服務分散化、全通路分銷和監管如何共同重塑胃造瘻管護理的策略和病患體驗

胃造瘻管領域正經歷變革時期，這場變革的驅動力來自技術進步、醫療服務分散化以及以使用者為中心的設計理念。低輪廓裝置和固定機制的創新提高了舒適度，減少了患者的恥辱感，從而提高了門診患者及其看護者的接受度。材料的進步，例如聚氨酯和矽膠配方的改進，逐步提升了生物相容性和耐用性，從而減少了更換頻率和裝置相關併發症。

了解2025年關稅變化對醫療設備供應鏈的採購、製造韌性、採購合約和監管協調的影響

2025年美國關稅調整對醫療設備製造商及其商業夥伴的供應鏈、籌資策略和成本管理產生了實際的影響。關稅導致進口零件和成品到岸成本增加，迫使各企業重新評估其籌資策略，許多企業開始尋求近岸製造、多源採購策略或垂直整合的供應鏈結構，以降低波動風險。這些策略轉變直接影響採購計畫、生產升級的資金分配以及無菌生產能力的地理分佈。

詳細的細分洞察揭示了設備類型、臨床環境、通路、臨床適應症、年齡層和材料選擇如何決定產品類型、適用性和服務需求。

對產品和商業性細分市場的分析揭示了不同設備類型、臨床環境和患者群體在應用和服務需求方面的差異。傳統導管和Low profile導管之間的產品類型細分定義了核心應用場景。傳統導管配置包括球囊和球頂固定機制的各種變體，每種變體都會影響留置技術、維護程序和併發症。同時，Low profile導管涵蓋球囊和水充氣固定方式，優先考慮低可見度和患者舒適度。最終用戶細分突顯了門診手術中心、居家醫療、醫院和專科診所之間在營運和支援需求方面的差異。在居家醫療領域，專科護理和自我管理應用場景需要不同的培訓計劃和耗材商品搭售。醫院又細分為綜合醫院和專科醫院，這兩者在採購規模和臨床手術量方面有差異。

區域法規結構、醫療服務模式和分銷基礎設施將如何影響美洲、歐洲、中東和非洲以及亞太地區的臨床應用和商業策略

區域趨勢正在影響主要地理區域的胃造瘻管護理臨床實踐模式、監管重點和商業管道。美洲擁有多元化的醫療保健系統，涵蓋大規模綜合醫院網路和廣泛的居家醫療生態系統。這種多樣性推動了對機構級傳統胃造瘻管和病患友善型、低調系統的強勁需求，同時注重高效的採購流程和上市後的臨床支援。該地區的臨床指南和支付方框架強調結果追蹤和成本效益，鼓勵相關人員將器材選擇與更廣泛的基於價值的醫療保健舉措相結合。

競爭和策略趨勢強調臨床證據、整合服務交付、供應鏈韌性和數位化參與，以實現永續優勢。

胃造瘻管領域的競爭格局已不再僅由價格驅動，而是更重視產品差異化、服務整合與實證實踐。領先的製造商和創新新興企業正積極投資臨床研究，以證明其產品能夠減少器械相關併發症、提高患者生活品質並簡化看護者的工作流程。策略性措施包括拓展產品線，涵蓋傳統型和小型化胃造瘻管；創建將器械供應、臨床醫生培訓和病患教育相結合的服務包；以及與居家醫療機構和專科診所合作，確保提供端到端的護理路徑。

製造商和醫療保健領導者可採取的切實可行的策略重點，以提高產品易用性、證據產生、分銷範圍和供應鏈韌性。

產業領導者應優先採取一系列切實可行的行動，將洞察轉化為臨床應用、供應鏈韌性和商業性績效等方面的可衡量成果。首先，產品開發藍圖應與看護者的易用性和居家照護需求保持一致，推動對低調設計和可減少維護並提高患者舒適度的固定機制的投資。同時，探索可簡化滅菌和生產流程且維持臨床性能的材料創新，從而支持供應鏈的柔軟性。

一種透明的多來源調查方法，結合了臨床醫生參與、監管審查、採購實踐分析以及嚴格的結果交叉檢驗。

本分析的調查方法結合了結構化的原始研究（包括與領域專家的訪談）、對同行評審臨床文獻的系統性回顧，以及對醫療服務機構中觀察到的採購和分銷實踐模式的三角驗證。原始數據包括對臨床醫生、供應鏈經理、居家醫療協調員和醫療設備技術人員的訪談，旨在了解實際環境中設備性能的操作細節和注意事項。次要資料包括設備標籤資訊、監管申報文件、來自臨床註冊機構的公開資料以及程序最佳實踐指南，以檢驗臨床和安全性特徵。

本文簡要概述了決定管飼護理長期應用和價值創造的關鍵醫療設備、臨床、商業和營運問題。

總而言之，胃造瘻管市場格局正受到多種因素的共同影響而重塑：旨在提升病患舒適度和便於居家管理的創新產品、強調門診和居家照護的醫療服務模式轉變、機構和消費者通路分銷的多元化，以及推動供應鏈重組的宏觀經濟壓力。這些趨勢共同促使製造商、醫療服務提供者和採購團隊採取整合策略，將設備設計、實證實踐、服務提供和營運韌性視為相互依存的優先事項。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依材質的醫用胃造瘻管市場

  • 聚氨酯
  • 矽酮

9. 依適應症分類的醫用胃造瘻管市場

  • 癌症
  • 胃腸道營養障礙
  • 遺傳性疾病
  • 神經系統疾病

第10章 依病人年齡分類的醫用胃造瘻管市場

  • 成人版
  • 老年人
  • 兒童

第11章 依最終使用者分類的醫用胃造瘻管市場

  • 門診手術中心
  • 居家照護
    • 專科護理
    • 自我管理
  • 醫院
    • 綜合醫院
    • 專科醫院
  • 專科診所

第12章 按分銷管道分類的醫用胃造瘻管市場

  • 離線
  • 線上
    • 製造商官方網站
    • 電子商務平台

第13章 各地區醫用胃造瘻管市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫療胃造瘻管市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫用胃造瘻管市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫用胃造瘻管市場

第17章：中國醫用胃造瘻管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • ConMed Corporation
  • Cook Medical LLC
  • Danone SA
  • Degania Medical Devices Ltd.
  • Fresenius SE & Co. KGaA
  • Global Medikit Limited
  • GST Corporation Limited
  • Halyard Health, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medicina Ltd.
  • Medtronic plc
  • Poly Medicure Limited
  • Romsons International
  • Teleflex Incorporated
  • Vygon SA
Product Code: MRR-7A380DA7C436

The Medical Gastrostomy Tube Market was valued at USD 1.11 billion in 2025 and is projected to grow to USD 1.21 billion in 2026, with a CAGR of 10.22%, reaching USD 2.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.11 billion
Estimated Year [2026] USD 1.21 billion
Forecast Year [2032] USD 2.19 billion
CAGR (%) 10.22%

Defining the clinical importance and evolving role of gastrostomy tubes across care settings while highlighting operational and patient-centered imperatives

Gastrostomy tubes serve as essential conduits for enteral nutrition and therapeutic administration in patients who cannot adequately ingest or absorb nutrients orally. These devices span a spectrum from traditional external tubes to low-profile internal systems designed to minimize stigma and facilitate daily living. As clinical practice shifts toward ambulatory and home-based care, the role of gastrostomy devices has expanded beyond acute hospital settings into long-term management of chronic neurological conditions, oncologic support, and complex genetic disorders that impair swallowing or digestion.

Clinical decision-making increasingly balances device selection with patient lifestyle, caregiver capability, and reimbursement parameters. Advances in material science and retention mechanisms have created options that reduce complications such as leakage, dislodgement, and local infection. At the same time, rising emphasis on patient-centered care and shorter inpatient stays places pressure on manufacturers and care providers to deliver safer, easier-to-manage products and comprehensive caregiver training.

In parallel, supply chain and distribution dynamics are reshaping how devices reach end users, with direct hospital procurement, online channels, and retail pharmacies each demanding different packaging, documentation, and service models. Stakeholders must therefore coordinate across clinical, commercial, and regulatory domains to ensure consistent standards of care while responding to evolving payer expectations and operational realities.

How product innovation, decentralizing care, omnichannel distribution, and regulatory scrutiny are jointly redefining strategy and patient experience in gastrostomy care

The gastrostomy tube landscape is undergoing a period of transformative change driven by technological refinement, care delivery decentralization, and user-centric design priorities. Low-profile devices and innovations in retention mechanisms have improved comfort and reduced stigma, enabling broader acceptance among ambulatory patients and caregivers. Material advances such as refined polyurethane and silicone formulations have incrementally enhanced biocompatibility and resilience, which in turn reduce replacement frequency and device-related complications.

Concurrently, care delivery is shifting away from prolonged hospitalization toward home-based management and ambulatory procedural settings, raising the importance of product ease-of-use and a seamless post-procedural support infrastructure. Telehealth and remote monitoring solutions are beginning to intersect with device management, enabling clinicians to extend follow-up and troubleshooting into the home environment and to triage issues before they escalate.

Commercially, distribution models are diversifying as manufacturers and suppliers adapt to omnichannel expectations; direct tender and hospital supply integrations remain central for institutional customers, while online sales and retail pharmacy access are expanding reach into home care markets. Regulatory emphasis on patient safety and post-market surveillance has encouraged manufacturers to invest in clinical evidence and training programs, and reimbursement bodies are increasingly scrutinizing total cost of care rather than unit price alone. These interconnected shifts are collectively raising the bar for product differentiation and service-led value propositions.

Understanding how 2025 tariff changes have reshaped sourcing, manufacturing resilience, procurement contracts, and regulatory coordination in medical device supply chains

United States tariff adjustments in 2025 have introduced tangible ripple effects across supply chains, procurement strategies, and cost management for medical device manufacturers and their commercial partners. Tariff-driven increases in the landed cost of imported components and finished devices have prompted organizations to re-evaluate sourcing strategies, with many pursuing nearer-shore manufacturing, multi-sourcing, or vertically integrated supply arrangements to mitigate volatility. These strategic shifts have direct implications for procurement timelines, capital allocation for manufacturing upgrades, and the geographic footprint of sterile production capacity.

Procurement teams and hospital supply chains are responding by recalibrating inventory policies and contract structures to maintain continuity of care while protecting margin. In some instances, longer lead times and higher input costs have accelerated collaboration between manufacturers and large institutional buyers to develop fixed-price or hedged contract mechanisms that stabilize unit costs without compromising supply reliability. Manufacturers prioritizing tariff sensitivity have intensified focus on design for manufacturability and material substitution where clinically appropriate, seeking to preserve clinical performance while optimizing component cost and regulatory compliance.

Regulatory and quality teams face increased complexity as production shifts or material changes necessitate supplementary validation and documentation. Consequently, cross-functional coordination between commercial, regulatory, and supply chain teams has become essential to manage product introductions and lifecycle changes. Overall, the tariff environment has acted as a catalyst for structural resilience planning, encouraging investments in flexible manufacturing, supplier diversification, and contractual frameworks that align clinical continuity with economic stability.

Detailed segmentation-driven insights revealing how device type, care setting, distribution routes, clinical indication, age groups, and material choices determine product fit and service needs

Analysis of the product and commercial segmentation landscape reveals differentiated adoption and service requirements across device types, care settings, and patient populations. Product Type distinctions between Conventional Tube and Low Profile Tube define core use cases; Conventional Tube configurations include Balloon Retention Mechanism and Dome Retention Mechanism variants, each carrying implications for placement technique, maintenance protocols, and complication profiles, while Low Profile Tube options span Balloon Retention Mechanism and Water Inflated Retention formats that prioritize low visibility and patient comfort. End User segmentation highlights divergent operational and support needs across Ambulatory Surgical Center, Home Care, Hospitals, and Specialty Clinics; within Home Care the split between Professional Care and Self-Administered use cases dictates differing training programs and consumable bundling, and Hospitals subdivided into General Hospitals and Specialty Hospitals show variance in procurement scale and clinical procedure volume.

Distribution Channel dynamics encompass Direct Tender, Hospital Supply Chain, Online Sales, and Retail Pharmacy pathways; the Online Sales channel itself bifurcates into Manufacturer Website and Third-Party Platform routes, each requiring tailored service levels, documentation, and returns handling. Indication-driven segmentation for Cancer, Digestive Nutritional Disorder, Genetic Disorder, and Neurological Disorder identifies the clinical contexts that most frequently necessitate gastrostomy access and therefore shape device feature prioritization, such as feeding port ergonomics or anti-reflux design. Patient Age cohorts-Adult, Geriatric, and Pediatric-introduce age-specific considerations in tube diameter, securement strategies, and caregiver education requirements. Finally, Tube Material choices between Polyurethane and Silicone influence flexibility, patient tolerance, and long-term wear characteristics.

Taken together, these segmentation dimensions interact to create nuanced product-market fit scenarios. For example, low-profile, water-inflated retention systems often align with self-administered home care for pediatric and adult ambulatory patients who prioritize discreetness and ease of daily management, whereas conventional dome-retention configurations may remain preferred in high-volume hospital settings where rapid placement and established protocols dominate. Distribution channel selection further modulates service expectations; hospitals tend to prefer integrated supply agreements with robust clinical training, while online and retail channels necessitate clear consumer-facing instructions and accessible customer support. These layered insights inform targeted product development, tailored clinical support packages, and differentiated commercial strategies that respond to the distinct needs of each segmentation intersection.

How regional regulatory frameworks, care delivery models, and distribution infrastructures across Americas, EMEA, and Asia-Pacific shape clinical adoption and commercial strategy

Regional dynamics shape clinical practice patterns, regulatory priorities, and commercial channels for gastrostomy tube care across major geographic blocs. In the Americas, healthcare systems range from large integrated hospital networks to extensive home care ecosystems; this diversity drives strong demand for both institutional-grade conventional tubes and patient-friendly low-profile systems, with an emphasis on streamlined procurement processes and post-market clinical support. Clinical guidelines and payer frameworks in this region emphasize outcome tracking and cost-effectiveness, prompting stakeholders to align device selection with broader value-based care initiatives.

Europe, Middle East & Africa presents a complex mosaic of regulatory regimes and care delivery infrastructures, where national reimbursement policies and local clinical practice influence device adoption. Specialty hospitals and tertiary centers often lead in adopting novel retention mechanisms and materials, while home care expansion in select markets increases the importance of caregiver training and distributor partnerships. Manufacturers operating in this region benefit from robust clinical networks but must navigate varied reimbursement environments and localization requirements.

Asia-Pacific encompasses a rapidly evolving mix of developed and emerging healthcare systems with strong growth in ambulatory surgical centers and home-based care services. Local manufacturing capacity and regional regulatory harmonization efforts influence sourcing decisions, while consumer adoption of online channels supports expanded access to devices for home administration. Across all regions, differences in patient demographics, surgical practice patterns, and distribution infrastructure require region-specific go-to-market strategies and tailored evidence-generation priorities to support adoption and long-term device success.

Competitive and strategic company trends emphasizing clinical evidence, integrated service offerings, supply resilience, and digital engagement for sustainable advantage

Competitive dynamics in the gastrostomy tube space center on product differentiation, service integration, and evidence generation rather than mere price competition. Leading manufacturers and innovative challengers are investing in clinical studies that demonstrate reductions in device-related complications, improvements in quality of life, and simplified caregiver workflows. Strategic moves include portfolio expansion to cover both conventional and low-profile offerings, the creation of bundled service packages that combine device supply with clinician training and patient education, and partnerships with home health providers and specialty clinics to secure end-to-end care pathways.

Operational excellence is a critical source of competitive advantage; firms that optimize supply chain resilience, maintain rigorous quality systems, and offer rapid clinical support for procedural teams tend to secure stronger hospital relationships. At the same time, companies that develop compelling direct-to-consumer initiatives-comprehensive instructional content, easy re-order pathways, and responsive customer service-can capture share within home care and self-administered segments. Regulatory engagement and proactive post-market surveillance are also differentiators, as payers and procurement leaders increasingly demand robust safety data and transparent complaint handling.

Finally, acquisition and partnership activity continues to shape the landscape as manufacturers seek scale in distribution and complementary technologies. Investors and strategic buyers are attracted to firms that demonstrate a blend of clinical credibility, established institutional contracts, and scalable consumer-facing capabilities, underscoring the importance of integrated commercial models that bridge hospital procurement and home care adoption.

Actionable strategic priorities for manufacturers and healthcare leaders to improve product usability, evidence generation, distribution reach, and supply chain resilience

Industry leaders should prioritize a set of pragmatic actions to convert insight into measurable outcomes across clinical adoption, supply resilience, and commercial performance. First, align product development roadmaps with caregiver usability and home care requirements, investing in low-profile designs and retention mechanisms that reduce maintenance burden and improve patient comfort. Simultaneously, explore material innovations that maintain clinical performance while simplifying sterilization and production processes to support supply chain flexibility.

Second, strengthen omnichannel distribution capabilities by harmonizing documentation, training resources, and ordering workflows across direct tender, hospital supply, online manufacturer portals, third-party platforms, and retail pharmacy partners. This alignment reduces friction for both institutional purchasers and individual caregivers. Third, build rigorous clinical and economic evidence packages that address safety endpoints, complication reduction, and total cost of care. Tailored real-world studies and collaboration with specialty clinics can accelerate payer acceptance and institutional adoption.

Fourth, implement supply chain resilience measures such as multi-sourcing, strategic inventory buffering for critical components, and geographically diversified manufacturing to mitigate tariff and trade disruptions. Fifth, enhance post-market support through clinician education, caregiver training modules, and telehealth-enabled troubleshooting to improve patient adherence and reduce avoidable readmissions. Finally, pursue strategic partnerships with home health providers and specialty centers to create integrated care pathways that demonstrate improved outcomes and strengthen long-term procurement relationships.

Transparent multi-source research methodology combining clinician engagement, regulatory review, procurement practice analysis, and rigorous cross-validation of findings

Research methodology for this analysis combined structured primary engagement with domain experts, systematic review of peer-reviewed clinical literature, and triangulation of procurement and distribution practice patterns observed in healthcare delivery settings. Primary inputs included interviews with clinicians, supply chain managers, home health coordinators, and device engineers to capture operational nuances and real-world device performance considerations. Secondary inputs encompassed device labeling, regulatory filings, clinical registry publications, and procedural best-practice guidance to validate clinical and safety characteristics.

Analytical approaches integrated qualitative thematic synthesis with comparative assessment of device design attributes, retention mechanisms, and material properties to identify recurring performance differentiators. Distribution and commercial channel analysis drew on procurement documentation patterns and publicly disclosed tender frameworks to map typical contractual structures and service expectations. To ensure rigor, findings were cross-validated across stakeholder groups and reconciled against clinical literature and regulatory summaries.

Limitations include variable transparency of proprietary contract terms and heterogeneity in regional clinical practice that may influence local adoption dynamics. Where possible, the methodology explicitly notes contextual dependencies and suggests follow-up primary research to address market-specific questions. The approach emphasizes reproducibility and clarity, enabling stakeholders to adapt the framework to their internal datasets and decision-making processes.

Concise synthesis of the device, clinical, commercial, and operational imperatives that will determine long-term adoption and value creation in gastrostomy care

In summary, the gastrostomy tube landscape is being reshaped by intersecting forces: product innovation aimed at patient comfort and ease of home management, shifting care delivery models that emphasize ambulatory and home-based services, distribution diversification across institutional and consumer channels, and macroeconomic pressures that prompt supply chain reconfiguration. These dynamics collectively require manufacturers, providers, and procurement teams to adopt integrated strategies that consider device design, evidence generation, service delivery, and operational resilience as interdependent priorities.

Sustained success will depend on the ability to deliver clinically robust devices that are supported by comprehensive training, rapid post-market responsiveness, and distribution models that meet the distinct expectations of hospitals, home care providers, and individual caregivers. By focusing on value-based outcomes, strengthening supplier and manufacturing flexibility, and investing in consumer-oriented support mechanisms, stakeholders can improve patient experience while navigating regulatory and commercial complexity. The collective emphasis on safety, simplicity, and support forms the foundation for long-term adoption and clinical benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Gastrostomy Tube Market, by Tube Material

  • 8.1. Polyurethane
  • 8.2. Silicone

9. Medical Gastrostomy Tube Market, by Indication

  • 9.1. Cancer
  • 9.2. Digestive Nutritional Disorder
  • 9.3. Genetic Disorder
  • 9.4. Neurological Disorder

10. Medical Gastrostomy Tube Market, by Patient Age

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Medical Gastrostomy Tube Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Home Care
    • 11.2.1. Professional Care
    • 11.2.2. Self-Administered
  • 11.3. Hospitals
    • 11.3.1. General Hospitals
    • 11.3.2. Specialty Hospitals
  • 11.4. Specialty Clinics

12. Medical Gastrostomy Tube Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online
    • 12.2.1. Manufacturer Website
    • 12.2.2. eCommerce Platform

13. Medical Gastrostomy Tube Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Gastrostomy Tube Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Gastrostomy Tube Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Gastrostomy Tube Market

17. China Medical Gastrostomy Tube Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Applied Medical Technology, Inc.
  • 18.6. Avanos Medical, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. Cardinal Health, Inc.
  • 18.10. ConMed Corporation
  • 18.11. Cook Medical LLC
  • 18.12. Danone S.A.
  • 18.13. Degania Medical Devices Ltd.
  • 18.14. Fresenius SE & Co. KGaA
  • 18.15. Global Medikit Limited
  • 18.16. GST Corporation Limited
  • 18.17. Halyard Health, Inc.
  • 18.18. Integra LifeSciences Holdings Corporation
  • 18.19. Medicina Ltd.
  • 18.20. Medtronic plc
  • 18.21. Poly Medicure Limited
  • 18.22. Romsons International
  • 18.23. Teleflex Incorporated
  • 18.24. Vygon S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DIGESTIVE NUTRITIONAL DISORDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DIGESTIVE NUTRITIONAL DISORDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DIGESTIVE NUTRITIONAL DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENETIC DISORDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENETIC DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PROFESSIONAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PROFESSIONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PROFESSIONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SELF-ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SELF-ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ECOMMERCE PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ECOMMERCE PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 160. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 187. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 196. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 199. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)